EVGN's logo.
Ticker Symbol: EVGN

Evogene Ltd

$2.31 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001574565

Company Profile

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.

Sector: Manufacturing
Industry: Pesticide and Other Agricultural Chemical Manufacturing
Standard Industrial Classification Code (SIC code): 2879
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.55
Change: -$0.03 ( -5.90%)
Days Range: $0.53 - $0.60
Beta: 1.06
52wk. High: $1.44
52wk. Low: $0.45
Ytd. Change -21.17%
50 Day Moving Average: $0.60
200 Day Moving Average: $0.75
Shares Outstanding: 41260439

Valuation

Market Cap: 2.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A